gvtcx

supplier

Ferring Pharmaceuticals Ltd

UB77PS combined from 2 published records

as a supplier

45 recorded awards from 9 buyers , between 8 Jan 2018 and 24 Mar 2025.

awards won
45
exclusive
0%
0 sole-winner awards
median award
£356.9m
largest
£469.7m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) shared NHS England £1 4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 31 Jul 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England Framework Agreement: South of England (Tranche B) shared NHS England £501,400,000 13 Sept 2018
NHS England Framework Agreement - London - Tranche A shared NHS England £211,435,404 14 Aug 2018
NHS Framework Agreement - North of England - Tranche B shared NHS England £521,100,000 13 Feb 2018
NHS Framework Agreement - North of England - Tranche B shared NHS England £521,100,000 8 Jan 2018
NHS England Framework Agreement: Midlands and East (Tranche A) shared NHS England £163,000,000 8 Jan 2018
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 shared Regional Business Services Organisation, Procurement and Logistics Service · 3 Jul 2026
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 shared Regional Business Services Organisation, Procurement and Logistics Service · 3 Jul 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
Proprietary Drugs shared eTenderwales · 28 Jul 2025
Gastrointestinal, Endocrine, Nutrition & Blood Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 25 Jul 2025

every contract won by Ferring Pharmaceuticals Ltd →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Ferring Pharmaceuticals Ltd · · 35
Ferring Pharmaceuticals Limited GB-COH 01198007 UB7 7PS 10

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works